Diamonds and Dogs

7/29/19

Good news, the CEO is leaving. Generic drug company, Mylan (MYL) is up 9% after agreeing to combine with Pfizer's off-patent branded and generic established medicines business. Pfizer shareholders will own 57% of the combined company, while Mylan shareholders will own 43%. Mylan is up over 13%. The good news is the current Mylan CEO, Heather Bresch will retire from Mylan upon the close of this transaction. Even with today's bump, Mylan's stock is at a seven year low.

So much for a trade deal. The chip stocks are taking a hit after President Trump indicated that a trade deal with China may not be reached until after the presidential election in 2020. DRAM chip company, Micron (MU) is down 2% after rallying 40% since mid-June following better than expected earnings.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.